tiprankstipranks
Cellectar Biosciences (DE:NV4P)
FRANKFURT:NV4P

Cellectar Biosciences (NV4P) Financial Statements

0 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Cellectar Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -6.14M$ -5.92M$ -5.82M$ -6.03M$ -6.36M
EBITDA$ -6.10M$ -5.88M$ -5.78M$ -5.99M$ -6.32M
Net Income Common Stockholders$ -6.14M$ -5.92M$ -5.82M$ -6.03M$ -6.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.09M$ 10.61M$ 18.84M$ 22.45M$ 30.63M
Total Assets$ 31.99M$ 37.20M$ 41.95M$ 47.74M$ 55.06M
Total Debt$ 235.60K$ 275.55K$ 314.68K$ 352.31K$ 389.21K
Net Debt$ -6.86M$ -10.34M$ -18.53M$ -22.10M$ -30.24M
Total Liabilities$ 4.78M$ 4.16M$ 3.37M$ 3.75M$ 5.29M
Stockholders Equity$ 5.25M$ 9.06M$ 16.22M$ 19.99M$ 27.21M
Cash Flow-
Free Cash Flow$ -5.07M$ -4.64M$ -6.43M$ -6.88M$ -4.75M
Operating Cash Flow$ -5.04M$ -4.51M$ -6.43M$ -6.88M$ -4.75M
Investing Cash Flow$ -30.07K$ -129.74K$ -4.06K$ -7.56K$ 0.00
Financing Cash Flow$ 0.00$ -1.00$ 0.00$ 34.87K$ 1.21M
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis